Similarly, IL-1β-deficient mice injected orthotopically with BC cells showed initial tumor growth, followed by regression linked to recruitment of alternative inflammatory monocytes and increased IL-12 secretion, promoting anti-tumor immunity and CD8+ T-cell activation [110]. The gene discussed is CD8A; the disease is breast cancer.